EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinical Immunology for Heart Transplant Nurses: Medication Decision-Making

Bernice Coleman, Ariz Amoroso Guzman, Ashley A Vo

AACN Advanced Critical Care · 15.06.2026 · 37 (2) · 185-203

DOI: 10.4037/aacnacc2026133 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift AACN Advanced Critical Care, erschienen am 15.06.2026. Verfasst von Bernice Coleman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bernice Coleman is Director, Nursing Research and Quality Improvement; Research Scientist III Nurse Practitioner, Heart Transplantation and Mechanica…. Hauptthemen laut MEDLINE: Heart Transplantation, Graft Rejection, Immunosuppressive Agents, Critical Care Nursing. Die Arbeit nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart transplantation offers life-saving therapy for patients with end-stage heart disease, but outcomes depend on precise management of immune risk and immunosuppression. The transplanted heart is a potent antigenic stimulus that can trigger immune pathways, leading to rejection and graft dysfunction if not adequately controlled. Intensive care unit nurses and advanced practice registered nurses need a working knowledge of transplant immunology because daily decisions about rejection surveillance, immunosuppressive medication management, early recognition of rejection risk, and patient education are grounded in these mechanisms. Recipient alloactivation occurs through direct and indirect pathways that shape the timing and phenotype of rejection. Acute cellular rejection is primarily T-cell mediated through major histocompatibility complex interactions, while antibody-mediated rejection is driven by donor-specific antibodies against human leukocyte antigens with complement activation and endothelial injury. This review links core immunology to bedside medication monitoring and safer, consistent post-transplant care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart TransplantationGraft RejectionImmunosuppressive AgentsCritical Care NursingPractice Guidelines as TopicHumansFemaleMaleMiddle AgedAdult

Stichwörter der Autor:innen

gene expression profilesheart transplantationimmunosuppressionrejection typestransplantation immunology

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Bernice Coleman is Director, Nursing Research and Quality Improvement; Research Scientist III Nurse Practitioner, Heart Transplantation and Mechanical Circulatory Support Programs; Assistant Professor, Biomedical Scienc…
  • Ariz Amoroso Guzman is Clinical Nurse III, 6NW Surgical/Transplant PCU; Postdoctoral Researcher, Nursing Research and Quality Department, Cedars-Sinai Medical Center, Los Angeles, California.
  • Ashley A. Vo is Professor of Pediatrics, David Geffen School of Medicine at University of California, Los Angeles; Director, Transplant Immunotherapy Program, Comprehensive Transplant Center, Cedars-Sinai Medical Center…

Zitieren

APA

Coleman, B., Guzman, A. A., & Vo, A. A. (2026). Clinical Immunology for Heart Transplant Nurses: Medication Decision-Making. AACN Advanced Critical Care, 37(2), 185-203. https://doi.org/10.4037/aacnacc2026133

Vancouver

Coleman B, Guzman AA, Vo AA. Clinical Immunology for Heart Transplant Nurses: Medication Decision-Making. AACN Advanced Critical Care. 2026;37(2):185-203. doi:10.4037/aacnacc2026133

BibTeX
@article{Coleman2026,
  author = {Coleman, Bernice and Guzman, Ariz Amoroso and Vo, Ashley A},
  title = {Clinical Immunology for Heart Transplant Nurses: Medication Decision-Making},
  journal = {AACN Advanced Critical Care},
  year = {2026},
  volume = {37},
  number = {2},
  pages = {185--203},
  doi = {10.4037/aacnacc2026133}
}
Kostenlos starten →